Naureen Quibria
Stock Analyst at Capital One
(0)
# 5141
Out of 5,329 analysts
15
Total ratings
11.11%
Success rate
-44.82%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
BMEA Biomea Fusion | Initiates Coverage On: Overweight | 25 | 2.17 | 1052.07% | 1 | Aug 29, 2024 | |
IMMP Immutep | Initiates Coverage On: Overweight | 10 | 1.72 | 481.4% | 1 | May 17, 2024 | |
ERAS Erasca | Initiates Coverage On: Overweight | 8 | 1.57 | 409.55% | 1 | Mar 11, 2024 | |
CARM CARISMA Therapeutics | Initiates Coverage On: Overweight | 10 | 0.23 | 4247.83% | 1 | Oct 3, 2023 | |
IMCR Immunocore Hldgs | Initiates Coverage On: Overweight | 84 | 30.88 | 172.02% | 1 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 2 | Apr 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 40 | 7.95 | 403.14% | 1 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 11 | 6.38 | 72.41% | 1 | Sep 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 7 | n/a | n/a | 2 | Sep 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 21 | 3.97 | 428.97% | 1 | Jan 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 22 | n/a | n/a | 1 | Dec 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 900 | 4.08 | 21958.82% | 1 | Oct 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 35 | n/a | n/a | 1 | Mar 16, 2021 |